Booster Dose Vaccine Receives Fast-Track Approval

Expedited Approval for Booster Shot Vaccines NEW YORK (AA)- Applications for booster doses of COVID-19 vaccines produced by Moderna and Johnson&Johnson in the United States have been approved. The U.S. Food and Drug Administration (FDA) granted "emergency use authorization" for booster doses of COVID-19 vaccines produced by both Moderna and Johnson & Johnson, and also announced that any of the three approved vaccines could be used as a booster through a "mix and match" approach. According to the FDA's statement, Americans aged 65 and older or those aged 18 and older working in high-risk occupations who received their second COVID-19 vaccine dose at least 6 months ago will be able to receive a Moderna booster shot, while those aged 18 and older who received the Johnson & Johnson vaccine can receive a booster dose 2 months after the initial shot. It remains to be seen whether the FDA will approve the Pfizer-BioNTech vaccine for children aged 5 to 11 in the coming weeks.